Skip to main content
Erschienen in: Inflammation 3/2016

16.04.2016 | ORIGINAL ARTICLE

Lipoic Acid Exerts Antioxidant and Anti-inflammatory Effects in Response to Heat Shock in C2C12 Myotubes

verfasst von: Cheng-Tse Lee, Li-Ching Chang, Pei-Fung Wu

Erschienen in: Inflammation | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

This study explored that lipoic acid treatment for 24 h significantly upregulated and promoted heat shock-induced catalase expression and downregulated GPx1 messenger RNA (mRNA) expression, indicating that lipoic acid exhibits antioxidant activity in the decomposition of hydrogen peroxide by upregulating catalase expression. Moreover, lipoic acid treatment for 3 h increased and promoted heat shock-induced interleukin (IL)-6 mRNA and protein levels and that for 24 h downregulated IL-6 mRNA expression, suggesting a dual effect of lipoic acid on IL-6 regulation. Lipoic acid alone failed to increase or reduce tumor necrosis factor (TNF)-α mRNA and protein levels, whereas heat shock alone downregulated TNF-α mRNA and protein expression. These data suggest that lipoic acid does not have a proinflammatory role and that heat shock acts as an anti-inflammatory agent by downregulating TNF-α expression in C2C12 myotubes. Moreover, lipoic acid or heat shock alone upregulated the IL-6 receptor (IL-6R-α) and glycoprotein 130 (gp130) mRNA expression followed by IL-6 expression; these data indicate that the regulation of lipoic acid or heat shock is mediated by IL-6R signaling, thus suggesting that C2C12 myotubes possesses a mechanism for regulating IL-6R and gp130 expression following lipoic acid treatment or heat shock.
Literatur
1.
Zurück zum Zitat Akerfelt, M., R.I. Morimoto, and L. Sistonen. 2010. Heat shock factors: integrators of cell stress, development and lifespan. Nature Reviews Molecular Cell Biology 11: 545–555.CrossRefPubMedPubMedCentral Akerfelt, M., R.I. Morimoto, and L. Sistonen. 2010. Heat shock factors: integrators of cell stress, development and lifespan. Nature Reviews Molecular Cell Biology 11: 545–555.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Demarco, V.G., P.O. Scumpia, J.P. Bosanquet, and J.W. Skimming. 2004. Alpha-lipoic acid inhibits endotoxin-stimulated expression of iNOS and nitric oxide independent of the heat shock response in RAW 264.7 cells. Free Radical Research 38: 675–682.CrossRefPubMed Demarco, V.G., P.O. Scumpia, J.P. Bosanquet, and J.W. Skimming. 2004. Alpha-lipoic acid inhibits endotoxin-stimulated expression of iNOS and nitric oxide independent of the heat shock response in RAW 264.7 cells. Free Radical Research 38: 675–682.CrossRefPubMed
3.
Zurück zum Zitat Tyagi, N., and R. Tyagi. 2015. The wonderous chaperones: a highlight on therapeutics of cancer and potentially malignant disorders. Journal of Oral and Maxillofacial Pathology 19: 212–220.CrossRefPubMedPubMedCentral Tyagi, N., and R. Tyagi. 2015. The wonderous chaperones: a highlight on therapeutics of cancer and potentially malignant disorders. Journal of Oral and Maxillofacial Pathology 19: 212–220.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wieten, L., F. Broere, R. van der Zee, E.K. Koerkamp, J. Wagenaar, and W. van Eden. 2007. Cell stress induced HSP are targets of regulatory T cells: a role for HSP inducing compounds as anti-inflammatory immuno-modulators? FEBS Letters 581: 3716–3722.CrossRefPubMed Wieten, L., F. Broere, R. van der Zee, E.K. Koerkamp, J. Wagenaar, and W. van Eden. 2007. Cell stress induced HSP are targets of regulatory T cells: a role for HSP inducing compounds as anti-inflammatory immuno-modulators? FEBS Letters 581: 3716–3722.CrossRefPubMed
5.
Zurück zum Zitat Kim, I., H.M. Shin, and W. Baek. 2005. Heat-shock response is associated with decreased production of interleukin-6 in murine aortic vascular smooth muscle cells. Naunyn-Schmiedeberg's Archives of Pharmacology 371: 27–33.CrossRefPubMed Kim, I., H.M. Shin, and W. Baek. 2005. Heat-shock response is associated with decreased production of interleukin-6 in murine aortic vascular smooth muscle cells. Naunyn-Schmiedeberg's Archives of Pharmacology 371: 27–33.CrossRefPubMed
6.
Zurück zum Zitat Pockley, A.G., S.K. Calderwood, and G. Multhoff. 2009. The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions? Cell Stress & Chaperones 14: 545–553.CrossRef Pockley, A.G., S.K. Calderwood, and G. Multhoff. 2009. The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions? Cell Stress & Chaperones 14: 545–553.CrossRef
7.
Zurück zum Zitat Bast, A., and G.R. Haenen. 1988. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochimica et Biophysica Acta 963: 558–561.CrossRefPubMed Bast, A., and G.R. Haenen. 1988. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochimica et Biophysica Acta 963: 558–561.CrossRefPubMed
8.
Zurück zum Zitat Maczurek, A., K. Hager, M. Kenklies, M. Sharman, R. Martins, J. Enge, D.A. Carlson, and G. Münch. 2008. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Advanced Drug Delivery Reviews 60: 1463–1470.CrossRefPubMed Maczurek, A., K. Hager, M. Kenklies, M. Sharman, R. Martins, J. Enge, D.A. Carlson, and G. Münch. 2008. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Advanced Drug Delivery Reviews 60: 1463–1470.CrossRefPubMed
9.
Zurück zum Zitat Petronilho, F., D. Florentino, L.G. Danielski, L.C. Vieira, M.M. Martins, A. Vieira, S. Bonfante, M.P. Goldim, and F. Vuolo. 2015. Alpha-Lipoic Acid Attenuates Oxidative Damage in Organs After Sepsis. Inflammation Oct 2. Petronilho, F., D. Florentino, L.G. Danielski, L.C. Vieira, M.M. Martins, A. Vieira, S. Bonfante, M.P. Goldim, and F. Vuolo. 2015. Alpha-Lipoic Acid Attenuates Oxidative Damage in Organs After Sepsis. Inflammation Oct 2.
10.
Zurück zum Zitat Gorąca, A., H. Huk-Kolega, A. Piechota, P. Kleniewska, E. Ciejka, and B. Skibska. 2011. Lipoic acid—biological activity and therapeutic potential. Pharmacological Reports 63: 849–858.CrossRefPubMed Gorąca, A., H. Huk-Kolega, A. Piechota, P. Kleniewska, E. Ciejka, and B. Skibska. 2011. Lipoic acid—biological activity and therapeutic potential. Pharmacological Reports 63: 849–858.CrossRefPubMed
11.
Zurück zum Zitat Gianturco, V., A. Bellomo, E. D'Ottavio, V. Formosa, A. Iori, M. Mancinella, G. Troisi, and V. Marigliano. 2009. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Archives of Gerontology and Geriatrics 49(Suppl 1): 129–133.CrossRefPubMed Gianturco, V., A. Bellomo, E. D'Ottavio, V. Formosa, A. Iori, M. Mancinella, G. Troisi, and V. Marigliano. 2009. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Archives of Gerontology and Geriatrics 49(Suppl 1): 129–133.CrossRefPubMed
12.
Zurück zum Zitat Kiemer, A.K., C. Müller, and A.M. Vollmar. 2002. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunology and Cell Biology 80: 550–557.CrossRefPubMed Kiemer, A.K., C. Müller, and A.M. Vollmar. 2002. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunology and Cell Biology 80: 550–557.CrossRefPubMed
13.
Zurück zum Zitat Zhang, W.J., and B. Frei. 2001. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. The FASEB Journal 15: 2423–2432.CrossRefPubMed Zhang, W.J., and B. Frei. 2001. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. The FASEB Journal 15: 2423–2432.CrossRefPubMed
14.
Zurück zum Zitat Wong, A., S. Dukic-Stefanovic, J. Gasic-Milenkovic, R. Schinzel, H. Wiesinger, P. Riederer, and G. Münch. 2001. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. European Journal of Neuroscience 14: 1961–1967.CrossRefPubMed Wong, A., S. Dukic-Stefanovic, J. Gasic-Milenkovic, R. Schinzel, H. Wiesinger, P. Riederer, and G. Münch. 2001. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. European Journal of Neuroscience 14: 1961–1967.CrossRefPubMed
15.
Zurück zum Zitat Bierhaus, A., S. Chevion, M. Chevion, M. Hofmann, P. Quehenberger, T. Illmer, T. Luther, E. Berentshtein, H. Tritschler, M. Müller, P. Wahl, R. Ziegler, and P.P. Nawroth. 1997. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46: 1481–1490.CrossRefPubMed Bierhaus, A., S. Chevion, M. Chevion, M. Hofmann, P. Quehenberger, T. Illmer, T. Luther, E. Berentshtein, H. Tritschler, M. Müller, P. Wahl, R. Ziegler, and P.P. Nawroth. 1997. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46: 1481–1490.CrossRefPubMed
16.
Zurück zum Zitat Wollin, S.D., and P.J.H. Jones. 2003. α-lipoic acid and cardiovascular disease. Journal of Nutrition 133: 3327–3330.PubMed Wollin, S.D., and P.J.H. Jones. 2003. α-lipoic acid and cardiovascular disease. Journal of Nutrition 133: 3327–3330.PubMed
17.
Zurück zum Zitat Xiao, Z.Q., L. Moragoda, R. Jaszewski, J.A. Hatfield, S.E.G. Fligiel, and A.P.N. Majumdar. 2001. Aging is associated with increased proliferation and decreased apoptosis in the colonic mucosa. Mechanisms of Ageing and Development 122: 1849–1864.CrossRefPubMed Xiao, Z.Q., L. Moragoda, R. Jaszewski, J.A. Hatfield, S.E.G. Fligiel, and A.P.N. Majumdar. 2001. Aging is associated with increased proliferation and decreased apoptosis in the colonic mucosa. Mechanisms of Ageing and Development 122: 1849–1864.CrossRefPubMed
18.
Zurück zum Zitat Bertolotto, F., and A. Massone. 2012. Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy. Drugs in R&D 12: 29–34.CrossRef Bertolotto, F., and A. Massone. 2012. Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy. Drugs in R&D 12: 29–34.CrossRef
19.
Zurück zum Zitat Hirano, T. 1998. Interleukin 6 and its receptor: ten years later. International Reviews of Immunology 16: 249–284.CrossRefPubMed Hirano, T. 1998. Interleukin 6 and its receptor: ten years later. International Reviews of Immunology 16: 249–284.CrossRefPubMed
20.
Zurück zum Zitat Conti, B., I. Tabarean, C. Andrei, and T. Bartfai. 2004. Cytokines and fever. Frontiers in Bioscience 9: 1433–1449.CrossRefPubMed Conti, B., I. Tabarean, C. Andrei, and T. Bartfai. 2004. Cytokines and fever. Frontiers in Bioscience 9: 1433–1449.CrossRefPubMed
21.
Zurück zum Zitat Nagaraju, K., N. Raben, G. Merritt, L. Loeffler, K. Kirk, and P. Plotz. 1998. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clinical and Experimental Immunology 113: 407–414.CrossRefPubMedPubMedCentral Nagaraju, K., N. Raben, G. Merritt, L. Loeffler, K. Kirk, and P. Plotz. 1998. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clinical and Experimental Immunology 113: 407–414.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Ostrowski, K., T. Rohde, M. Zacho, S. Asp, and B.K. Pedersen. 1998. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. The Journal of Physiology 508: 949–953.CrossRefPubMedPubMedCentral Ostrowski, K., T. Rohde, M. Zacho, S. Asp, and B.K. Pedersen. 1998. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. The Journal of Physiology 508: 949–953.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kosmidou, I., T. Vassilakopoulos, A. Xagorari, S. Zakynthinos, A. Papapetropoulos, and C. Roussos. 2002. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. American Journal of Respiratory Cell and Molecular Biology 26: 587–593.CrossRefPubMed Kosmidou, I., T. Vassilakopoulos, A. Xagorari, S. Zakynthinos, A. Papapetropoulos, and C. Roussos. 2002. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. American Journal of Respiratory Cell and Molecular Biology 26: 587–593.CrossRefPubMed
24.
Zurück zum Zitat Welc, S.S., N.A. Phillips, J. Oca-Cossio, S.M. Wallet, D.L. Chen, and T.L. Clanton. 2012. Hyperthermia increases interleukin-6 in mouse skeletal muscle. American Journal of Physiology - Cell Physiology 303: C455–466.CrossRefPubMedPubMedCentral Welc, S.S., N.A. Phillips, J. Oca-Cossio, S.M. Wallet, D.L. Chen, and T.L. Clanton. 2012. Hyperthermia increases interleukin-6 in mouse skeletal muscle. American Journal of Physiology - Cell Physiology 303: C455–466.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Welc, S.S., A.R. Judge, and T.L. Clanton. 2013. Skeletal muscle interleukin-6 regulation in hyperthermia. American Journal of Physiology - Cell Physiology 305: C406–413.CrossRefPubMed Welc, S.S., A.R. Judge, and T.L. Clanton. 2013. Skeletal muscle interleukin-6 regulation in hyperthermia. American Journal of Physiology - Cell Physiology 305: C406–413.CrossRefPubMed
26.
Zurück zum Zitat Pedersen, B.K., and M.A. Febbraio. 2008. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiological Reviews 88: 1379–1406.CrossRefPubMed Pedersen, B.K., and M.A. Febbraio. 2008. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiological Reviews 88: 1379–1406.CrossRefPubMed
27.
Zurück zum Zitat Portier, G.L., A.G. Benders, A. Oosterhof, J.H. Veerkamp, and T.H. van Kuppevelt. 1999. Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium. In Vitro Cellular and Developmental Biology Animal 35: 219–227.CrossRefPubMed Portier, G.L., A.G. Benders, A. Oosterhof, J.H. Veerkamp, and T.H. van Kuppevelt. 1999. Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium. In Vitro Cellular and Developmental Biology Animal 35: 219–227.CrossRefPubMed
28.
Zurück zum Zitat Wu, P.F., S.C. Luo, and L.C. Chang. 2015. Heat-shock-induced glucose transporter 4 in the slow-twitch muscle of rats. Physiological Research 64: 523–530.PubMed Wu, P.F., S.C. Luo, and L.C. Chang. 2015. Heat-shock-induced glucose transporter 4 in the slow-twitch muscle of rats. Physiological Research 64: 523–530.PubMed
29.
Zurück zum Zitat Fridovich, I. 1995. Superoxide radical and superoxide dismutases. Annual Review of Biochemistry 64: 97–112.CrossRefPubMed Fridovich, I. 1995. Superoxide radical and superoxide dismutases. Annual Review of Biochemistry 64: 97–112.CrossRefPubMed
30.
Zurück zum Zitat Kirkman, H.N., and G.F. Gaetani. 2007. Mammalian catalase: a venerable enzyme with new mysteries. Trends in Biochemical Sciences 32: 44–50.CrossRefPubMed Kirkman, H.N., and G.F. Gaetani. 2007. Mammalian catalase: a venerable enzyme with new mysteries. Trends in Biochemical Sciences 32: 44–50.CrossRefPubMed
31.
Zurück zum Zitat Chada, S., C. Whitney, and P.E. Newburger. 1989. Post-transcriptional regulation of glutathione peroxidase gene expression by selenium in the HL-60 human myeloid cell line. Blood 74: 2535–2541.PubMed Chada, S., C. Whitney, and P.E. Newburger. 1989. Post-transcriptional regulation of glutathione peroxidase gene expression by selenium in the HL-60 human myeloid cell line. Blood 74: 2535–2541.PubMed
32.
Zurück zum Zitat Mihara, M., M. Hashizume, H. Yoshida, M. Suzuki, and M. Shiina. 2012. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clinical Science (London, England : 1979) 122: 143–159.CrossRef Mihara, M., M. Hashizume, H. Yoshida, M. Suzuki, and M. Shiina. 2012. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clinical Science (London, England : 1979) 122: 143–159.CrossRef
33.
Zurück zum Zitat Rose-John, S. 2012. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. International Journal of Biological Sciences 8: 1237–1247.CrossRefPubMedPubMedCentral Rose-John, S. 2012. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. International Journal of Biological Sciences 8: 1237–1247.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Muñoz-Cánoves, P., C. Scheele, B.K. Pedersen, and A.L. Serrano. 2013. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS Journal 280: 4131–4148.CrossRefPubMedPubMedCentral Muñoz-Cánoves, P., C. Scheele, B.K. Pedersen, and A.L. Serrano. 2013. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS Journal 280: 4131–4148.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Kostek, M.C., K. Nagaraju, E. Pistilli, A. Sali, S.H. Lai, B. Gordon, and Y.W. Chen. 2012. IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse. BMC Musculoskeletal Disorders 13: 106.CrossRefPubMedPubMedCentral Kostek, M.C., K. Nagaraju, E. Pistilli, A. Sali, S.H. Lai, B. Gordon, and Y.W. Chen. 2012. IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse. BMC Musculoskeletal Disorders 13: 106.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Starkie, R., S.R. Ostrowski, S. Jauffred, M. Febbraio, and B.K. Pedersen. 2003. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. The FASEB Journal 17: 884–886.PubMed Starkie, R., S.R. Ostrowski, S. Jauffred, M. Febbraio, and B.K. Pedersen. 2003. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. The FASEB Journal 17: 884–886.PubMed
37.
Zurück zum Zitat Jones, S.A., J. Scheller, and S. Rose-John. 2011. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. The Journal of Clinical Investigation 121: 3375–3383.CrossRefPubMedPubMedCentral Jones, S.A., J. Scheller, and S. Rose-John. 2011. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. The Journal of Clinical Investigation 121: 3375–3383.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Kishimoto, T. 2010. IL-6: from its discovery to clinical applications. International Immunology 22: 347–352.CrossRefPubMed Kishimoto, T. 2010. IL-6: from its discovery to clinical applications. International Immunology 22: 347–352.CrossRefPubMed
39.
Zurück zum Zitat Burton, M.D., N.L. Sparkman, and R.W. Johnson. 2011. Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior. Journal of Neuroinflammation 8: 54.CrossRefPubMedPubMedCentral Burton, M.D., N.L. Sparkman, and R.W. Johnson. 2011. Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior. Journal of Neuroinflammation 8: 54.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Campbell, I.L., M. Erta, S.L. Lim, R. Frausto, U. May, S. Rose-John, J. Scheller, and J. Hidalgo. 2014. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. The Journal of Neuroscience 34: 2503–2513.CrossRefPubMed Campbell, I.L., M. Erta, S.L. Lim, R. Frausto, U. May, S. Rose-John, J. Scheller, and J. Hidalgo. 2014. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. The Journal of Neuroscience 34: 2503–2513.CrossRefPubMed
Metadaten
Titel
Lipoic Acid Exerts Antioxidant and Anti-inflammatory Effects in Response to Heat Shock in C2C12 Myotubes
verfasst von
Cheng-Tse Lee
Li-Ching Chang
Pei-Fung Wu
Publikationsdatum
16.04.2016
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2016
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0350-2

Weitere Artikel der Ausgabe 3/2016

Inflammation 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.